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 Higher plants produce diverse low-molecular-weight chemicals such as 
alkaloids, terpenoids and phenylpropanoid compounds. Among these chemicals, 
alkaloids are particularly important in medicine due to their high biological activities. 
However, the low yield of metabolites, especially alkaloids, in plants limits large-scale 
development of the plant natural product industry. In this chapter, I describe the 
metabolic engineering of plants to improve the yield and quality of useful secondary 
metabolites and their potentials. Among alkaloids, I focus on the production of 
isoquinoline alkaloids (IQAs), since their biosynthesis has been most intensively studied 
at the molecular level and their application in metabolic engineering has also been 
intensively examined. Based on our understanding of IQA engineering, I discuss its 
application to the production of other alkaloids through similar approaches.  
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 Higher plants produce diverse low-molecular-weight chemicals such as 
alkaloids, terpenoids and phenylpropanoid compounds (Croteau et al., 2000).  
Although these compounds are widely used for health and nutrition in humans, 
alkaloids are particularly important in medicine due to their high biological activities. 
However, the low yield of metabolites, especially alkaloids, in plants limits large-scale 
development of the plant natural product industry. Thus, many research groups have 
tried to establish production systems using the micropropagation of elite plant clones, 
cell culture and organ culture based on incomplete information regarding biosynthesis 
of these metabolites. Over the past 20 years, our understanding of the biochemistry and 
molecular biology of natural products, including alkaloids, has rapidly expanded.  
Based on knowledge regarding biosynthetic enzymes and their corresponding genes, the 
modification of productivity and metabolic profiles has become possible (Sato et al., 
2007a; Sato & Yamada, 2008). Furthermore, the microbial production of plant 
metabolites through the reconstruction of plant biosynthetic pathways has become 
feasible (Chow & Sato, 2013; Hawkins & Smolke, 2008; Minami et al., 2008; 
Nakagawa et al., 2011; see also Chapter 7). Metabolic engineering in plant cells has 
advantages and disadvantages. In this chapter, I discuss its potentials and pitfalls based 
on our experience. 
 
2. Isoquinoline alkaloid biosynthesis and pathway characterization 
 
 Due to technological difficulties in the cultivation and relatively slow growth 
of medicinal plants, plant cell and tissue cultures have been intensively examined for 
the production of secondary metabolites (Sato & Yamada, 2008; Verpoorte et al., 1991). 
Whereas the selection of high-yield lines and treatment with an elicitor such as methyl 
jasmonate has enabled the industrial production of some metabolites, e.g., 
shikonin-production in selected Lithospermum erythrorhizon cells, or paclitaxel 
production in Pacific yew cell cultures with methyl jasmonate, it is quite difficult to 
achieve both high productivity and stability for industrial application (Sato & Yamada, 
2008). While the development of hairy roots by the transformation of plant cells with 
Agrobacterium rhizogenes provides a solution with unlimited growth, morphological 
differentiation of roots for physical strength, high potential for the mass-production of 
valuable secondary metabolites, and greater genetic stability, for fermentation, we need 
a much faster growth of cells/tissues, higher productivity and improved quality of 
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metabolites (for details of cell culture techniques, please see Sato & Yamada, 2008).  
 Recent advances in molecular biology have provided tools for metabolic 
engineering. The identification of many genes of biosynthetic enzymes and 
characterization of the spatial and developmental regulation of their expression have 
clarified their roles in the biosynthesis of secondary metabolites and provided strategies 
for metabolic engineering such as the trimming of undesired pathways, the 
enhancement of rate-limiting steps and the introduction of new pathways to produce 
novel compounds (Sato et al., 2007a,b). 
 Isoquinoline alkaloid (IQA) biosynthesis provides a good model in metabolic 
engineering, since it has been intensively studied at the molecular level and 
experimentally challenged. The biosynthetic pathway for IQAs starts with L-tyrosine, as 
shown in Figure 1. Among IQAs, the biosynthesis of benzylisoquinoline alkaloid from 
norcoclaurine has been the most investigated to date. All of the enzyme genes of the 
total nine enzymatic reaction steps from norcoclaurine to berberine have been 
characterized at the DNA level (Fig. 1): a norcoclaurine synthase  (NCS; an entry 
enzyme in IQA biosynthesis, PR10 family such as TfNCS from Thalictrum flavum (Lee 
& Facchini, 2010; Samanani et al., 2004) and a novel dioxygenase-like protein, 
CjNCS1, from Coptis japonica (Minami et al., 2007)), an N-methyltransferase 
(coclaurine N-methyltransferase (CNMT, Choi et al., 2002)), three O-methyltransferases 
(OMTs; norcoclaurine 6OMT, 3'-hydroxy-N-methyl-coclaurine 4'OMT (6OMT, 4'OMT, 
Morishige et al., 2000), (S)-scoulerine 9-O-methyltransferase (SMT, Takeshita et al., 
1995), a hydroxylase (CYP80B1, Pauli & Kutchan, 1998), a berberine bridge enzyme 
(BBE, Dittrich & Kutchan, 1991), a methylenedioxy ring-forming enzyme (canadine 
synthase; CYP719A1, Ikezawa et al., 2003), and a tetrahydroprotoberberine oxidase 
(THBO, Gesell et al., 2011; Matsushima et al., 2012).  
 
>>Insert Figure 1 here  
 
 The number of available enzyme genes is growing rapidly (Figs. 1 and 2): the 
genes of corytuberine synthase in aporphine biosynthesis (CYP82G2, Ikezawa et al., 
2008); those of salutaridine synthase (CYP719B1, Gesell et al., 2009), salutaridine 
reductase (SalR, Ziegler et al., 2006), salutaridinol-7-O-acetyltransferase (SalAT, 
Grothe et al., 2001), thebaine 6-O-demethylase and codeine O-demethylase (T6ODM, 
CODM, Hagel & Facchini, 2010) and NADPH-dependent codeinone reductase (COR, 
Unterlinner et al., 1999) in morphinan alkaloid biosynthesis; those of chelanthifoline 
synthase (CYP719A5, Ikezawa et al., 2009), stylopine synthase (CYP719A2/A3, 
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Ikezawa et al., 2007), (S)-cis-N-methylstylopine 14-hydroxylase (Beaudoin & Facchini, 
2013), protopine 6-hydroxylase (CYP82N2v2, Takemura et al., 2013), sanguinarine 
reductase (Vogel et al., 2010) and dihydrobenzophenanthridine oxidase (DBOX, Hagel 
et al., 2012) in benzophenanthridine biosynthesis; those of berbamunine synthase 
(CYP80A1, Kraus & Kutchan, 1995) in the bis-benzylisoquinoline alkaloid pathway; 
those of O-methyltransferases (Dang & Facchini, 2012) and a 10-gene cluster (three 
O-methyltransferases (PSMT1-3), four cytochrome P450s (CYP82X1/2, CYP82Y1 & 
CYP719A21), an acetyltransferase (PSAT1), a carboxylesterase (PSCXE1) and a 
short-chain dehydrogenase/reductase (PSSDR1)(Winzer et al., 2012) in noscapine 
biosynthesis and those of O-methyltransferases in emetine biosynthesis (IpeOMT1/2/3, 
CiOMT, Cheong et al., 2011; Nomura & Kutchan, 2010).  
 
>>Insert Figure 2 here  
 
 While many homologues are annotated after cloning of the first enzyme gene, 
we should pay close attention to the properties of each enzyme, since pathways in 
secondary metabolism are often diversified and connected in a complicated manner, 
based on the different substrate and reaction specificity of the enzyme acquired during 
the evolution of each species. For example, while Coptis japonica columbamine 
O-methyltransferase (CjCoOMT) can use both tetrahydrocolumbamine and 
columbamine in palmatine biosynthesis, columbamine was once thought to be the 
exclusive substrate of CoOMT in Berberis plants (Morishige et al., 2002). Similarly, 
CNMT of Coptis and Berberis showed different substrate specificities; i.e., the Coptis 
enzyme could N-methylate norlaudanosoline, while the Berberis enzyme could not. In 
this sense, the knowledge needed for both metabolic engineering and synthetic biology 
is still incomplete, and such information is greatly needed. We should be careful in the 
annotation of an enzyme gene simply based on homology, since only a few changes in 
amino acids can modify reaction specificities; e.g., Ipecac OMTs in emetine 
biosynthesis (Fig. 3; Cheong et al., 2011; Nomura & Kutchan, 2010). 
 
>>>Insert Figure 3 here   
 
3. Metabolic pathway engineering 
3.1. Pathway engineering with overexpression of the rate-limiting enzyme and 
transcription factors in alkaloid biosynthesis 
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 With an increase in the molecular tools available in metabolic engineering, we 
can now modulate the metabolic flow of plant cells. Among several strategies, 
overexpression of the gene for the enzyme in the rate-limiting step is commonly 
examined to improve the yield (Fig. 4). The overexpression of C. japonica SMT in the 
original cells was the first successful application of genetic engineering to IQA 
biosynthesis to increase berberine production (Sato et al., 2001), while 4'OMT 
overexpression was later successfully applied in intact plants (Inui et al., 2012). Allen et 
al. (2008) also reported that transgenic opium poppy with overexpression of SalAT had 
more than 30% greater total alkaloids than the control in three independent trials over 3 
years.  
 However, overexpression of an endogeneous gene can (often) induce the 
co-suppression of the gene and decrease the production of the end-metabolites 
(Jorgensen, 1995; Takemura et al., 2010a). Thus, heterologous expression of a 
homologue isolated from a different plant species is recommended. For example, 
Cj6OMT was expressed in California poppy (Eschschlozia californica) cells to 
overcome the rate-limiting step (Inui et al., 2007). Note that bottleneck step(s) may 
differ among plant species and cell lines due to variations in gene expression. In fact, 
the overexpression of Cj4'OMT was less effective for increasing alkaloid production 
than that of 6OMT in E. californica cells, whereas 4'OMT was effective in C. japonica 
plants (Inui et al., 2007, 2012). Changes in the bottleneck step may also occur after 
modification of the enzyme expression level through metabolic engineering.  
 Since there are multiple bottleneck steps and these limiting steps can change 
with overexpression of the enzyme in the limiting step, overall regulation of the 
expression levels of biosynthetic genes in the pathway is the preferred strategy.  
Whereas information about the transcription factors in alkaloid biosynthesis is very 
limited, several transcription factors, such as the ERF, WRKY and bHLH families in 
alkaloid biosynthesis, including IQA biosynthesis, have been isolated and characterized 
(Kato et al., 2007; Yamada et al., 2011a,b; Yamada & Sato, 2013). While experimental 
results suggest that the activities of native transcription factors can be fine-tuned 
spatially and temporally (see Yamada & Sato, 2013), the successful application of the 
overexpression of heterologous AtWRKY transcription factor in opium poppy to 
increase the morphinan alkaloid content (Apuya et al., 2008) suggests that transcription 
factors may be used to improve the yields of IQAs and other alkaloids.  
 




3.2. Pathway engineering with trimming of pathways and the introduction of new 
branch pathways 
 
 While an increase in the metabolite yield is important for industrial application, 
modification of the metabolite profile by the introduction of a new metabolic branching 
point and/or the trimming of undesired pathways is another important approach in drugs 
development.  
To increase metabolite diversity, we ectopically expressed CjSMT, which is 
involved in berberine biosynthesis but not in benzophenanthridine alkaloid biosynthesis, 
in California poppy (E. californica) cells (Fig. 5). CjSMT expression not only produced 
columbamine (oxidized product of tetrahydrocolumbamine) in transgenic E. californica 
cells (Sato et al., 2001) but also induced the accumulation of novel products, i.e., 
allocryptopine and 10-hydroxychelerythrine, derived from CjSMT reaction products by 
the endogenous enzyme reactions in E. californica cells, indicating that the alkaloid 
profile in transgenic cells was further diversified by the introduction of a branched 




>> Insert  Figure 5 here  
 
 While an increase in metabolite diversity is preferable for the screening of 
novel products, the reduction of undesired metabolic diversity is also required to 
prepare a single purified chemical and increase the metabolic flow to the desired 
compound. Among the methods for gene silencing (e.g., antisense, RNA silencing, 
knockout with T-DNA insertion, mutation,.. etc.), RNA silencing with double-stranded 
RNA molecules (RNA interference; RNAi with short interfering (si) RNA or micro (mi) 
RNA, co-suppression of gene expression with overexpression of a target gene, or 
virus-induced gene silencing (VIGS)) is the most powerful and reliable, although 
Transcription Activator-Like Effector Nucleases (TALEN) could be useful for preparing 
knockout mutant and novel mutants through homologous recombinants (Borgio, 2009; 
Desgagné-Penix & Facchini, 2012; Sato, 2005; Winzer et al., 2012; Zhang et al., 2013).  
 Successful RNAi of BBE in California poppy cells induced the accumulation of 
reticuline, a substrate of BBE (Fujii et al., 2007), whereas antisense RNA of BBE 
produced little accumulation of reticuline in transgenic cells (Park et al., 2002) (Fig. 6). 
However, there is another pitfall in effective gene silencing; e.g., an enhanced branch 
pathway from the accumulated reticuline to produce a byproduct, i.e., 
7-O-methylreticuline, which could scarcely be detected in control cells.  In addition, 
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suppression of a certain enzyme in a metabolic pathway may induce the unexpected 
disturbance of the pathway; e.g., RNAi of COR genes in opium poppy induced the 
accumulation of a far-upstream precursor, (S)-reticuline (Allen et al., 2004). The 
disturbance of metabolism by the down-regulation of enzyme expression can be partly 
explained by the accumulation of an intermediate and feedback regulation of the 
pathway, or the disruption of an enzyme complex (metabolome) to catalyze sequential 
reactions, or off-target effects of RNAi on other unexpected gene targets (Allen et al., 
2004, 2008).  
 
>>> Insert Figure 6 here 
 
 While simple overexpression of the rate-limiting step enzyme/transcription 
factors, introduction of a branch pathway and trimming of a pathway through the use of 
gene silencing are currently applied in metabolic engineering in alkaloid biosynthesis, 
the combination of these strategies provides a more effective approach for improving 
both the quantity and quality of metabolites. For example, trimming of the endogenous 
pathway with the introduction of new branch was critical for drastic modification of the 
metabolite in blue rose production; i.e., the accumulation of sufficient blue pigment, 
delphinidin, was only achieved by the combined expression of the gene for a novel blue 
pigment biosynthetic enzyme, i.e., flavonoid 3′,5′-hydroxylase, and the down-regulation 
of endogenous dihydroflavonol 4-reductase by RNAi to shut down the undesired red 
pigment pathway (Katsumoto et al., 2007). Such a combined approach can be 
performed with a transcription factor and an enzyme for a rate-limiting step that is not 
under the control of the introduced transcription factor. This can provide greater 
flexibility in metabolic engineering.  
 
4. Perspectives  
 While the biosynthetic pathways for many metabolites still require 
considerable characterization including of the involved enzymes and their genes, 
continued advances in molecular and genomic techniques will surely expand the 
production of useful natural products, especially alkaloids. Particularly, whole genome 
sequence data bring considerable information on biosynthesis along with rapidly 
accumulating RNA sequence data. The combined analysis of transcriptomes, proteomes, 
metabolomes and genomes provides a new approach for identifying the candidate genes 
in uncharacterized pathways (Dang & Facchini, 2012; Desgagné-Penix et al., 2010, 
2012; Farrow et al., 2012; Takemura et al., 2010b; Winzer et al., 2012). The 
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establishment of transcriptome and proteome databases for the investigation of natural 
product metabolism in non-model plant systems has provided useful information for 
metabolic engineering. Desgagné-Penix et al. (2010) showed that profiling of the 
more-abundant proteins in elicitor-treated opium poppy cell cultures revealed several 
uncharacterized enzymes that potentially catalyze steps in sanguinarine biosynthesis. 
 Structural biology also provides important cues for isolating key biosynthetic 
enzymes in pathways and their molecular functions, although structural information 
regarding the biosynthetic enzymes in secondary metabolism is very limited (Ilari et al., 
2009; Wallner et al., 2012; Winkler et al., 2009). 
 Whereas we can use both plant and microbial cells as a platform for metabolite 
production (Chow & Sato, 2013; see also Chapter 7), we should be aware of their pros 
and cons. For instance, while plant cell or tissue cultures can produce more divergent 
chemicals than microbial systems, their complexity and instability are problematic for 
industrial production. Microbial systems enable alkaloid production on a relatively large 
scale within a short period, but require more molecular informations on the biosynthetic 
pathways and enzymes, whereas the emergence of synthetic biology offers the 
possibility of improving the production of useful products through the design and 
engineering of complex biological systems. While computer-assisted molecular design 
software is being developed to facilitate the synthesis of novel compounds with 
drug-like properties and desired activities, the use of information science for the 
reconstruction of metabolic pathways, i.e., “retrobiosynthetic” systems, will require 
more experimental data on the identification and analysis of biosynthetic enzymes and 
pathways. However, technological progress has been quite rapid and provides us with 
many options. The potentials of metabolic engineering in secondary metabolism are 
unlimited.  
 
5.  Conclusion  
 Metabolic engineering as well as synthetic biological approaches are at the 
forefront in natural product research. Our experiences in IQA biosynthesis provide new 
clues for the molecular characterization of biosynthetic pathways and novel production 
systems for natural products. Technological advances, including next-generation 
sequencing, offer a bright future for the production of not only IQAs but also other 
alkaloids. This high potential in natural product research will require more sophisticated 
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Figure 1. Main pathway in isoquinoline alkaloid biosynthesis. Major isoquinoline 
alkaloids, such as aporphine-, benzophenanthridine- and protoberberine-type 
isoquinoline alkaloids, are synthesized through a common pathway derived from 
norcoclaurine to reticuline. Aporphine alkaloids are synthesized from (S)-reticuline by 
the reaction of corytuberine synthase (CYP80G2). Protoberberine and 
benzophenanthridine alkaloids are synthesized from (S)-scoulerine produced from 
(S)-reticuline by the reaction of berberine bridge enzyme (BBE). Ipecac and some other 
IQAs are synthesized from dopamine without norcoclaurine biosynthesis. The names of 
the biosynthetic enzymes for which cDNA has been isolated and characterized are 
shown. Abbreviations for biosynthetic enzymes are defined in the text, except for 
TYDC (tyrosine/DOPA decarboxylase; Facchini et al., 2000) and TyrAT (tyrosine 
aminotransferase; Lee & Facchini, 2011). 
 
Figure 2.  
Extended pathways in isoquinoline alkaloid biosynthesis; from reticuline to 
protoberberine, benzophenanthridine, morphinan and noscarpine alkaloids (a) 
Protoberberine and benzophenanthridine alkaloid biosynthesis has mainly been 
characterized in Coptis japonica (Cj) and Eschscholzia californica (Es) cells, while 
some genes have been isolated from Papaver somniferum (Ps). (b) Morphinan and 
noscarpine biosynthesis were characterized in Papaver somniferum. 
 The names of the biosynthetic enzymes for which cDNA has been isolated and 
characterized are shown. Abbreviations for biosynthetic enzymes are defined in the text, 
except for CoOMT (columbamine O-methyltransferase), and 7OMT (reticuline 
7-O-methyltransferase).  
 
Figure 3.   
Ipecac OMT alignment and reaction specificity 
 
Figure 4.  
Yield improvement by the ectopic expression of C. japonica (Cj) 6OMT in California 
poppy cells.   
 
Figure 5.  
Metabolic diversification by the introduction of a branch pathway 
The introduction of a novel branch pathway in California poppy induced the production 
of uncommon protoberberine-type alkaloids, whereas major products were further 
19 
 
metabolized to di-methoxy-type benzophenanthridine alkaloids by endogenous 
enzymes.  
 
Figure 6.  
Quality modification by the trimming of a pathway  
Knockdown of BBE expression with double-stranded RNA strongly reduced 
endogenous alkaloid accumulation and increased the accumulation of a precursor, 
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